By conducting these studies, researchers can elucidate the mechanisms by which GATA6 mutations disrupt pancreatic function and potentially identify therapeutic targets for developing novel interventions for monogenic diabetes associated with GATA6 variants. Here, GATA6 is linked to diabetes mellitus.